Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial
暂无分享,去创建一个
Daniel S Berman | Mihaela Aslan | Paul Kolm | William S Weintraub | John A Spertus | Leslee J Shaw | David J Cohen | D. Berman | L. Shaw | J. Spertus | P. Hartigan | W. Boden | K. Teo | W. Weintraub | G. Mancini | D. Cohen | Marcin R Dada | M. Knudtson | D. Maron | P. Kolm | M. Aslan | Koon K Teo | Steven P Sedlis | William E Boden | S. Sedlis | G B John Mancini | David J Maron | Pam Hartigan | Merril Knudtson | Marcin Dada | D. Cohen | A. Robert | O'Rourke
[1] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[2] E. Braunwald,et al. Economic Impact of Angina After an Acute Coronary Syndrome: Insights From the MERLIN-TIMI 36 Trial , 2009, Circulation. Cardiovascular quality and outcomes.
[3] Sankey V. Williams,et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physi , 2012, Circulation.
[4] K. Lee,et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. , 1994, The New England journal of medicine.
[5] D. Berman,et al. Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial , 2009, Circulation. Cardiovascular quality and outcomes.
[6] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[7] Peter C Austin,et al. The performance of different propensity score methods for estimating marginal hazard ratios , 2007, Statistics in medicine.
[8] Stanley E. Kaufman,et al. Effect of PCI on quality of life in patients with stable coronary disease. , 2008, The New England journal of medicine.
[9] S. Kaul,et al. From here to eternity: a unified kinetic model for the pathophysiology of atherosclerotic events. , 2007, The American journal of medicine.
[10] R A Deyo,et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.
[11] G. Lamas,et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.
[12] J. Spertus,et al. Monitoring the quality of life in patients with coronary artery disease. , 1994, The American journal of cardiology.
[13] M. Hlatky,et al. Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. , 1994, Archives of internal medicine.
[14] Ron Goeree,et al. Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients , 2008, Circulation. Cardiovascular quality and outcomes.
[15] B. McNeil,et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. , 1997, The New England journal of medicine.
[16] Benjamin S. Abella,et al. Circ Cardiovasc Qual Outcomes , 2013 .
[17] J. Spertus. Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment? , 2001, American heart journal.
[18] Sankey V. Williams,et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.
[19] Peter C Austin,et al. The performance of different propensity score methods for estimating marginal odds ratios, Statistics in Medicine 2007; 26:3078–3094 , 2008 .
[20] K A Eagle,et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.
[21] D. Berman,et al. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. , 2006, American heart journal.
[22] J. Spertus,et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.
[23] P. O'Gara. The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise? , 2010, Journal of the American College of Cardiology.
[24] J. Spertus,et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Th , 2009, Journal of the American College of Cardiology.
[25] David O. Williams,et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .
[26] Mario J. Garcia,et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] R. Brook,et al. Use of Coronary Artery Bypass Surgery in the United States and Canada , 1993 .
[28] P. Austin. The performance of different propensity score methods for estimating marginal odds ratios , 2007, Statistics in medicine.
[29] Peter C Austin,et al. A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003 , 2008, Statistics in medicine.
[30] D. Wennberg,et al. Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era , 2008, Circulation.
[31] L. Leape,et al. Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. , 2003, The New England journal of medicine.
[32] D. Berman,et al. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. , 2010, Journal of the American College of Cardiology.
[33] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[34] R. A. Johnson,et al. Prognostic value of a coronary artery jeopardy score. , 1985, Journal of the American College of Cardiology.
[35] J. Spertus,et al. Health Status Predicts Long-Term Outcome in Outpatients With Coronary Disease , 2002, Circulation.
[36] D. Mozaffarian,et al. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. , 2003, American heart journal.